🇺🇸 FDA
Patent

US 8084199

Method of diagnosing poor survival prognosis colon cancer using microRNA-21

granted A61PA61P1/04A61P35/00

Quick answer

US patent 8084199 (Method of diagnosing poor survival prognosis colon cancer using microRNA-21) held by THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH
Grant date
Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P1/04, A61P35/00